Adjuvants Based on Synthetic Mycobacterial Cord Factor Analogues: Biophysical Properties of Neat Glycolipids and Nanoself-Assemblies with DDA
- 31 May 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 14 (7) , 2294-2306
Abstract
Synthetic mycobacterial cord factor analogues, e.g., trehalose 6,6′-dibehenate (TDB), are highly promising adjuvants due to their strong immunopotentiating capabilities, but their biophysical properties have remained poorly characterized. Here, we report the synthesis of an array of synthetic TDB analogues varying in acyl chain length, degree of acylation, and headgroup display, which was subjected to biophysical characterization of neat nondispersed self-assembled nanostructures in excess buffer and as aqueous dispersions with cationic dimethyldioctadecylammonium (DDA) bromide. The array comprised trehalose mono- (TMX) and diester (TDX) analogues with symmetrically shortened acyl chains [denoted by X: arachidate (A), stearate (S), palmitate (P), myristate (Myr), and laurate (L)] and an analogue with a short hydrophilic polyethylene glycol (PEG) linker inserted between the trehalose headgroup of TDS and the acyl chains (PEG-TDS). All dispersions were liposomes, but in contrast to the colloidally stable and highly cationic TDX-containing liposomes, the zeta-potential was significantly reduced for DDA/TMX and DDA/PEG-TDS liposomes, suggesting a charge-shielding effect, which compromises the colloidal stability. An increased d-spacing was observed for the lamellar phase of neat TDB analogues in excess buffer (TDS < TMS < PEG-TDS), confirming that the charge shielding is caused by an extended molecular configuration of the more flexible headgroup. Differential scanning calorimetry showed highly cooperative phase transitions for all tested dispersions albeit the monoesters destabilized the lipid bilayers. Langmuir experiments demonstrated that incorporation of TDXs and PEG-TDS stabilized DDA monolayers due to improved hydrogen bonding and reduced intermolecular repulsions. In conclusion, data suggest that the DDA/TDS dispersions exhibit favorable physicochemical properties rendering these DDA/TDS liposomes an attractive vaccine adjuvant, and they emphasize that not only the receptor binding and immune activation but also the biophysical properties of immunopotentiator formulations should be collectively considered when designing adjuvants with optimal safety, efficacy, and storage stability.Keywords
Funding Information
- Sundhed og Sygdom, Det Frie Forskningsr?d (09-067412)
- Natur og Univers, Det Frie Forskningsr?d (10-085264)
- Styrelsen for Forskning og Innovation
- Strategiske Forskningsr?d (09-067052)
- Drug Research Academy, K?benhavns Universitet
- Innovationsfonden (007-2007-1, 069-2011-1)
This publication has 57 references indexed in Scilit:
- Modern Subunit Vaccines: Development, Components, and Research OpportunitiesChemMedChem, 2013
- Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin MincleJournal of Experimental Medicine, 2009
- Signalling through C-type lectin receptors: shaping immune responsesNature Reviews Immunology, 2009
- The path to a successful vaccine adjuvant – ‘The long and winding road’Drug Discovery Today, 2009
- Vaccine adjuvants: Current challenges and future approachesJournal of Pharmaceutical Sciences, 2009
- Bridging the knowledge gaps in vaccine designNature Biotechnology, 2007
- The perfect mix: recent progress in adjuvant researchNature Reviews Microbiology, 2007
- Trehalose 6,6′-Dimycolate and Lipid in the Pathogenesis of Caseating Granulomas of Tuberculosis in MiceThe American Journal of Pathology, 2006
- In Vivo Activity of Released Cell Wall Lipids of Mycobacterium bovis Bacillus Calmette-Guérin Is Due Principally to Trehalose MycolatesThe Journal of Immunology, 2005
- Targeting the innate immune response with improved vaccine adjuvantsNature Medicine, 2005